NCT02835339View on ClinicalTrials.gov

Magnesium Sulfate in Obese Preeclamptics

PHASE4CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 12, 2016

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Preeclampsia
Interventions
DRUG

Magnesium sulfate 4g loading dose, 1g/hr infusion

DRUG

Magnesium sulfate 6g loading dose, 2g/hr infusion

Trial Locations (1)

97239

Oregon Health & Science Univerity, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER

NCT02835339 - Magnesium Sulfate in Obese Preeclamptics | Biotech Hunter | Biotech Hunter